DDIT4 and breast carcinoma: We found that DDIT4‐AS1 was highly expressed in TNBC cell lines and clinical breast cancer samples, indicating that DDIT4‐AS1 possess potential to be a biomarker for the clinical diagnosis and treatment of TNBC.